We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-11.35%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
AUM
$20.6M
AUM Growth
-$3.88M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 75.93%
2 Consumer Discretionary 24.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMVP icon
1
PMV Pharmaceuticals
PMVP
$69.3M
$9.92M 48.05%
1,614,911
REAL icon
2
The RealReal
REAL
$1.37B
$4.97M 24.07%
2,354,080
SERA icon
3
Sera Prognostics
SERA
$86.1M
$4.49M 21.78%
2,416,241
GKOS icon
4
Glaukos
GKOS
$9.13B
$1.23M 5.96%
16,347
DARE icon
5
Dare Bioscience
DARE
$29.1M
$28.7K 0.14%
5,172

Similar funds

InterWest Venture Management's Q3 2023 Portfolio in Review

As of Q3 2023, InterWest Venture Management held 5 positions worth $20.6M, down 16% from $24.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. InterWest Venture Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 79% a quarter earlier, followed by Consumer Discretionary.

  • InterWest Venture Management's ten largest holdings make up 100% of its $20.6M portfolio in Q3 2023.
  • InterWest Venture Management opened 0 new positions and closed 0 in Q3 2023.
  • InterWest Venture Management's portfolio value fell 16% quarter-over-quarter to $20.6M.

Based on InterWest Venture Management's 13F filing for Q3 2023, filed 20 Oct 2023.